Immediate Impact
54 standout
Citing Papers
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial
2025 Standout
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Works of Suzanne Tavitian being referenced
CD34+CD38−CD123+ Leukemic Stem Cell Frequency Predicts Outcome in Older Acute Myeloid Leukemia Patients Treated by Intensive Chemotherapy but Not Hypomethylating Agents
2020
Emerging biological therapies to treat acute lymphoblastic leukemia
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Suzanne Tavitian | 455 | 116 | 167 | 195 | 58 | 831 | |
| Chirayu Auewarakul | 329 | 137 | 200 | 233 | 63 | 980 | |
| Charikleia Kelaïdi | 439 | 51 | 280 | 191 | 45 | 716 | |
| Norio Hirabayashi | 345 | 106 | 77 | 129 | 40 | 805 | |
| Muna Qayed | 191 | 71 | 183 | 270 | 80 | 838 | |
| Sumiko Kobayashi | 279 | 51 | 97 | 145 | 50 | 731 | |
| Martine J. Hollestelle | 404 | 80 | 89 | 132 | 33 | 822 | |
| I. J. Temperley | 261 | 67 | 228 | 122 | 56 | 748 | |
| Juan Eduardo Megías‐Vericat | 345 | 91 | 94 | 234 | 60 | 776 | |
| Hiroshi Tsutani | 426 | 174 | 127 | 321 | 77 | 948 | |
| Önder Arslan | 345 | 50 | 126 | 53 | 80 | 752 |
All Works
Login with ORCID to disown or claim papers
Loading papers...